Nu-Prep, perfect and official supplements 'extra push' Testosterone Management.

Nu-Prep, perfect and official supplements 'extra push' Testosterone Management.
Negative - Prohibited List. ADAMAS, New Delhi, India. NON-DRUG. Nu-Prep official supplement 'The National Sports Institute of Malaysia'

Wednesday, 2 September 2026

PHYSTA® — FROM 26 CLINICAL STUDIES TO AN EVIDENCE MATRIX. MERDEKA !

PHYSTA® — FROM 26 CLINICAL STUDIES TO AN EVIDENCE MATRIX

The scientific story. Testosterone Management.

MERDEKA, MERDEKA, MERDEKA

For more than 69 years, Malaysia has progressed from independence to building its own scientific and technological capability.

 

Tongkat Ali, Eurycoma longifolia, represents an especially interesting Malaysian example:

Traditional Malaysian knowledge → botanical resource → standardized extraction → analytical chemistry → quality control → human clinical research → evidence-based application.

 

That progression is what makes “Science First, Everything Follows” a meaningful positioning.

The key scientific issue is not simply whether a supplier can sell Eurycoma longifolia or even report a certain eurycomanone percentage.

 

The real question is:

Does the material being purchased reproduce the identity, chemical standardization, manufacturing characteristics, safety profile and clinically investigated material?

 

That is where the 26-study evidence base becomes important.

 

1. THE FOUR-PARAMETER STANDARDIZATION

Biotropics states that PHYSTA® is standardized using four characteristic parameters:

 

PARAMETER

SCIENTIFIC ROLE

Eurycomanone

 

Important quassinoid chemical marker

 

Total protein/peptides

 

Part of the standardized extract profile

 

Glycosaponins

 

Characteristic phytochemical fraction

 

Polysaccharides

 

Part of the standardized extract profile

 

 

Biotropics also states that PHYSTA® contains more than 65 compounds, meaning eurycomanone is a marker—not a complete chemical description of the extract.

https://z.biotropicsmalaysia.com/

This is a crucial distinction for your proposed evidence matrix:

Eurycomanone ≠ PHYSTA®

A supplier could theoretically match the eurycomanone number but still produce an extract with a different overall chemical profile.

 

Therefore:

Single-marker matching is weaker evidence than multi-parameter standardization.

 

2. THE 26-STUDY MATRIX SHOULD BE STRUCTURED BY EVIDENCE LEVEL

 

I recommend using five evidence columns, rather than simply “study name / result.”

A. Clinical question

What was the study actually trying to determine?

B. Population

Who was studied?

Men? Women? Ageing adults? Infertile men? Moderately stressed adults?

C. Intervention

What exact material and dose were used?

This is extremely important.

D. Endpoint

What was objectively measured?

Testosterone? Free testosterone? cortisol? sperm motility? MENQOL? muscle strength? immune markers?

E. Evidence strength

RCT / placebo-controlled / open-label / pilot / observational / preclinical.

 

This prevents very different studies from being presented as if they have identical evidentiary weight.

 

3. EXAMPLE OF THE EVIDENCE MATRIX

Based on the studies I could independently verify, the matrix begins like this:

Evidence area

Study / population

Design

INTERVENTION

MAIN FINDING

EVIDENCE WEIGHT

Testosterone/ ageing

 

105 men, 50-70

Randomized, double-blind, placebo-controlled, multicentre

 

PHYSTA® 100/200 mg/day, 12 weeks

 

↑ total testosterone; 200 mg also reduced cortisol and improved strength/QoL

 

High

Sexual health / QoL

 

109 men, 30–55

 

 

Randomized, double-blind, placebo-controlled

 

 

 

PHYSTA® 300 mg/day, 12 weeks

 

 

 

Improvements in physical functioning, erectile function, libido and semen parameters

 

High

 

Andropause / late-onset hypogonadism

 

76 men

 

Open-label

 

PHYSTA® 200 mg/day, 4 weeks

 

PHYSTA® 200 mg/day, 4 weeks

Reported improvements in testosterone status and ageing-male symptoms

 

Moderate–low

 

Male infertility

 

75 men with idiopathic infertility

 

Clinical intervention

 

PHYSTA® 200 mg/day, 3 months

 

Improvements reported in sperm concentration, motility and morphology; spontaneous pregnancies reported

 

Moderate

 

Immune function

 

Middle-aged adults

 

Randomized, double-blind, placebo-controlled

 

PHYSTA® 200 mg/day, 4 weeks

 

Changes in CD4+ T cells and other immune parameters

 

High

 

Stress / mood

 

Moderately stressed adults

 

Randomized placebo-controlled

 

PHYSTA® + multivitamins

 

Reduced stress and improved quality-of-life measures

 

Moderate–high

 

Strength / exercise

 

Middle-aged men with androgen-deficiency symptoms

 

Randomized, double-blind, placebo-controlled

 

PHYSTA® 200 mg/day + exercise

 

Greater improvement in strength than exercise alone

 

 

High

 

Menopause

 

138 women, 40–55

 

 

Randomized, double-blind, placebo-controlled

 

 

PHYSTA® 50/100 mg/day, 12 weeks

 

 

100 mg group showed significant improvement in total MENQOL and physical/sexual domains

 

High

 

Microbiome

 

55-year-old woman

 

 

Case study

 

 

PHYSTA® 100 mg/day, 30 days

 

Changes in microbial diversity and selected bacterial populations

 

Microbiome

Very preliminary

 

Metabolic mechanisms

 

Cell/animal models

 

Preclinical

 

PHYSTA®

 

Insulin secretion/glucose uptake and nephroprotective findings

 

Preclinical-not clinical efficacy

 

 

The testosterone RCT is particularly useful because it was registered, randomized, double-blind and placebo-controlled; PubMed reports that the 200 mg group had significant total-testosterone improvement, reduced cortisol and increased muscle strength, with no clinically relevant safety changes.

PubMed https://pubmed.ncbi.nlm.nih.gov/34262417/

The 109-man randomized trial is also independently available through PubMed/PMC and reported improvements in physical functioning and erectile-function measures, with semen-related outcomes and comparable safety parameters.

PubMed Central (PMC) +1 https://pmc.ncbi.nlm.nih.gov/articles/PMC3518798/?utm_source=chatgpt.com

 

The immune study was likewise randomized, double-blind and placebo-controlled.

PubMed https://pubmed.ncbi.nlm.nih.gov/26816234/

 

And the 2025 menopause study is particularly significant for your broader men + women scientific story: 138 women aged 40–55 were randomized to 50 mg, 100 mg or placebo; the 100 mg group had a statistically significant reduction in total MENQOL and improvements in physical and sexual domains.

PubMed Central (PMC) +1 https://pubmed.ncbi.nlm.nih.gov/41283187/

 

4. THE MOST IMPORTANT MATRIX: “MATERIAL → STANDARDIZATION → CLINICAL RESULT”

This is where I think your presentation can become much stronger.

Instead of saying:

“26 studies prove Tongkat Ali works.”

say:

“The 26-study evidence base must be interpreted together with the identity and standardization of the material that was actually investigated.”

Then create this chain:

BOTANICAL IDENTITY

Eurycoma longifolia

EXTRACTION

Standardized aqueous root extract

CHEMICAL STANDARDIZATION

Eurycomanone

protein/peptides

glycosaponins

polysaccharides

BATCH QUALITY

COA + analytical testing + contaminant testing + manufacturing controls

CLINICAL INVESTIGATION

Randomized / placebo-controlled / open-label / pilot studies

HUMAN ENDPOINTS

Testosterone

Stress

Cortisol

Sexual health

Fertility

Strength

Quality of life

Menopause

Immune parameters

EVIDENCE-BASED POSITIONING

That is far more defensible than using eurycomanone alone.

 

5. WHY A CHEAPER CHINESE EXTRACT CANNOT SIMPLY “INHERIT” THE 26 STUDIES

This is perhaps the strongest commercial/scientific message.

Imagine two extracts:

Extract A

Eurycomanone = 1.0%

PHYSTA®

Eurycomanone = 1.0%

It would be scientifically incorrect to conclude:

“Both are therefore clinically equivalent.”

Why?

Because the clinical evidence follows the investigated material, not merely the name of the plant or one analytical marker.

The 109-man clinical study specifically investigated a freeze-dried water extract identified as PHYSTA®.

PubMed Central (PMC)

The 2021 testosterone study likewise specifically investigated standardized aqueous-root PHYSTA®.

PubMed

And the menopause RCT explicitly describes the study product as standardized PHYSTA® water extract manufactured, packaged and registered by the study sponsor.

PubMed Central (PMC)

Therefore:

A COA can demonstrate what a new batch contains.

It cannot transfer somebody else's clinical results onto that batch.

That is a very powerful scientific principle.

 

6. COA — IMPORTANT, BUT NOT THE WHOLE EVIDENCE

I would therefore position COA as one layer of the evidence pyramid:

LEVEL 1 — IDENTITY

Is it genuinely Eurycoma longifolia?

LEVEL 2 — PURITY

Is it free from unacceptable contaminants/adulteration?

LEVEL 3 — STANDARDIZATION

Does it meet the defined chemical specifications?

LEVEL 4 — BATCH CONSISTENCY

Does batch after batch remain within specification?

LEVEL 5 — MANUFACTURING CONTROL

Is the extraction/manufacturing process controlled?

LEVEL 6 — SAFETY

Is there toxicological and human safety evidence?

LEVEL 7 — CLINICAL EVIDENCE

Has the actual standardized material been tested in humans?

LEVEL 8 — REPRODUCIBILITY

Can the clinical findings be reproduced across populations, studies and settings?

That is the real scientific hierarchy.

 

7. ONE VERY IMPORTANT CORRECTION TO THE “26 STUDIES” MESSAGE

I would not call all 26 studies equivalent clinical trials.

Biotropics' current page says PHYSTA® is supported by 26 clinical studies, but the same page also contains different evidence types—including randomized controlled trials, open-label studies, a case study and preclinical investigations.

biotropicsmalaysia.com +1

For credibility, your master document should therefore classify every study as:

RCT / controlled clinical / open-label / pilot / case study / observational / preclinical.

That actually strengthens the story because it shows scientific transparency.

🇲🇾 THE FINAL STORY

69 YEARS OF MERDEKA.

NOW, LET SCIENCE SPEAK.

Malaysia's independence gave us the freedom to build our own future.

Our biodiversity gave us the raw material.

Traditional knowledge gave us the starting point.

But science gave us the methodology to investigate it.

With Eurycoma longifolia, the journey moves from:

Forest → Root → Extraction → Standardization → COA → Laboratory → Clinical Trial → Human Evidence → Global Science.

And the lesson is simple:

A plant name is not a clinical result.

A single marker is not an entire extract.

A COA is not a clinical trial.

A cheap copy cannot automatically inherit another ingredient's evidence.

The real scientific value lies in controlling the entire chain.

Identity.

Standardization.

Quality.

Consistency.

Safety.

Clinical evidence.

And when those pieces come together, we move beyond traditional claims.

We move into evidence-based Malaysian science.

 

 

MALAYSIA — SCIENCE FIRST. EVERYTHING FOLLOWS.

69 years of Merdeka.

From Malaysian biodiversity to clinical science.

From traditional knowledge to evidence.

From Malaysia - to the world.

 

MERDEKA! MERDEKA! MERDEKA!  


Wednesday, 19 August 2026

PHYSTA® Tongkat Ali - The World’s Best Testosterone Management Solution

 PHYSTA® Tongkat Ali  -  The World’s Best Testosterone Management Solution

 Backed by 28 Studies & Proven Clinical Results.


Testosterone Management.
Tongkat Ali PHYSTA.


1. Standardized — The Gold Standard of Quality & Consistency

PHYSTA® is not a generic Tongkat Ali extract. It is the world’s first patented, standardized hot-water Tongkat Ali extract, developed through a landmark collaboration between the Malaysian Government & the Massachusetts Institute of Technology (MIT) .

 

https://www.frontiersin.org/10.3389%2fconf.fphar.2018.63.00054/event_abstract

https://www.biotropicsmalaysia.com/research/clinical-study-physta

 

Unlike conventional extracts with unpredictable potency, PHYSTA® is standardized to four bioactive markers, including Eurycomanone, total protein, total polysaccharide & glycosaponin - ensuring every batch delivers consistent, predictable levels of active compounds .

 

This standardization is certified in compliance with MS2409:2011 standards set by the Standard & Industrial Research Institute of Malaysia (SIRIM) .

 

For the international community, this means you know exactly what you are consuming — batch after batch, capsule after capsule. No guesswork. No inconsistency. Just pharmaceutical-grade precision from root to finished product .

 

2. Eurycomanone — The Scientifically Proven Bioactive Marker

 

Eurycomanone is the primary bioactive quassinoid responsible for Tongkat Ali’s testosterone-enhancing effects .

https://www.evigrade.com/en/drugs/tongkat-ali

 

 

 PHYSTA® is standardized to optimal Eurycomanone levels (typically 1.5–3%) , making it the most potent & reliable Tongkat Ali extract available.

 

How Eurycomanone works:

 

· Stimulates testosterone synthesis in Leydig cells through a 4.2 kDa bioactive peptide

· Inhibits the aromatase enzyme, which converts testosterone into estrogen - helping maintain a healthy testosterone-to-estrogen ratio

· Supports the hypothalamic-pituitary-gonadal (HPG) axis to naturally enhance endogenous testosterone production

 

This multi-pathway mechanism sets PHYSTA® apart from single-action supplements. It doesn’t just “boost” testosterone - it restores hormonal balance at the source.

 

https://www.biotropicsmalaysia.com/latest-news/physta-r-technology-things-you-should-know-about-the-worlds-first-patented-tongkat-ali-extract

 

3. Clinically Tested — Proven by 28 Studies & Rigorous Science

 

PHYSTA® is one of the most clinically studied Tongkat Ali extracts in the world, backed by over 20 clinical studies and 28+ research publications. Its efficacy is validated through multiple randomized, double-blind, placebo-controlled trials - the gold standard of clinical evidence .

 

Key Clinical Findings:

 

1. Testosterone Restoration in Aging Men (2021 Study)

A randomized, double-blind, placebo-controlled multicentre study enrolled 105 men aged 50–70 with testosterone <300 ng/dL. Results showed significant increases in total testosterone at weeks 4, 8, and 12 .

 

2. 37% Testosterone Increase & 16% Cortisol Reduction (2013 Study)

In moderately stressed adults, 200 mg/day of PHYSTA® produced a 37% increase in free testosterone alongside a 16% reduction in cortisol — demonstrating powerful adaptogenic effects for stress management and hormonal health .

 

3. 90.8% Normalization Rate in Hypogonadal Men (Tambi RCT, Andrologia 2012)

In 76 men with late-onset hypogonadism, PHYSTA® 200 mg/day for one month restored testosterone to normal range in 90.8% of subjects.

 

4. 2022 Systematic Review & Meta-Analysis

A comprehensive meta-analysis of five randomized controlled trials confirmed a significant increase in total testosterone following Eurycoma longifolia supplementation (SMD = 1.352, 95% CI 0.565 to 2.138, p = 0.001) .

 

5. Menopause Quality of Life (2025 Study)

In 138 perimenopausal and postmenopausal women, 100 mg/day PHYSTA® for 12 weeks produced a 33.9% reduction in menopausal symptoms - with significant improvements in physical & sexual domains .

 

Why PHYSTA® Is the World’s Best Tongkat Ali for Testosterone Management

 

Feature PHYSTA® Generic Extracts

Standardization Yes - 4 bioactive markers Rarely standardized

Eurycomanone Content Optimized (1.5–3%) Unknown / Inconsistent

Clinical Studies 28+ studies, multiple RCTs Few or none

MIT & Government Partnership Yes — patented technology No

SIRIM Certified Yes (MS2409:2011) No

Proven Testosterone Results 37% increase, 90.8% normalization Unverified

 

PHYSTA® is not merely a supplement - it is a science-backed, clinically proven solution for testosterone management. With 28 studies, multiple randomized controlled trials & a 2022 meta-analysis confirming its efficacy, PHYSTA® stands as the world’s most trusted & evidence-based Tongkat Ali extract.

 

For the international community seeking actual results with scientific certainty, PHYSTA® delivers the standardization, potency  & clinical proof that generic products simply cannot match.

 

Choose PHYSTA®. Choose science. Choose results.


Sunday, 9 August 2026

Testosterone Management. FROM MALAYSIAN TRADITION TO MODERN CLINICAL SCIENCE.

 FROM MALAYSIAN TRADITION TO MODERN CLINICAL SCIENCE

A New Perspective on Testosterone Management with PHYSTA® Tongkat Ali

For generations, Tongkat Ali (Eurycoma longifolia) has been part of Malaysia’s natural heritage. Traditionally valued for vitality, strength & wellbeing, this remarkable plant has travelled a long way from traditional use to the laboratory.

Today, the conversation is changing.

The question is no longer simply:

“Does Tongkat Ali work?” 

The more important question is:

“What does modern human clinical research tell us about how a standardized Tongkat Ali extract may support testosterone management?”

That is where PHYSTA® enters the story.

Testosterone Management Is More Than Raising a Number

Testosterone is an important hormone, but testosterone management should never be reduced to the idea of simply increasing a laboratory value.

Hormonal health exists within a much larger physiological system involving energy, physical function, stress, body composition, metabolic health, reproductive function & overall wellbeing.

For someone experiencing symptoms associated with low testosterone, the responsible starting point is therefore not immediately reaching for a supplement, testosterone therapy or any other intervention.

It starts with understanding the individual & measuring appropriately.

A healthcare professional may consider testosterone measurements together with the person's symptoms, medical history & other relevant investigations.

This is an important distinction.

Testosterone management should begin with measurement not assumption.

Where Does PHYSTA® Fit In?

PHYSTA® is a standardized water-soluble extract of Eurycoma longifolia developed from Malaysian Tongkat Ali.

Unlike testosterone replacement therapy, PHYSTA® does not supply testosterone directly to the body.

This is what makes the scientific question interesting.

Instead of asking whether we can simply put more testosterone into the body, researchers have investigated whether standardized Tongkat Ali can support the body's own hormonal environment & related physiological functions.

And this is where traditional knowledge meets modern clinical research.

PHYSTA® has been investigated in 26 clinical studies, covering different areas of human health & wellbeing.

But scientific credibility requires an important qualification:

The 26 studies should not be presented as 26 testosterone studies.

They represent a broader PHYSTA® clinical research programme. Testosterone - related claims should be connected specifically to the studies that actually investigated testosterone & related biomarkers.

That distinction is not a weakness.

It is what responsible science looks like.

What Did the Testosterone Research Actually Examine?

One particularly relevant randomized, double-blind, placebo-controlled multicentre clinical study evaluated 105 men aged 50–70 with low total testosterone over 12 weeks.

Researchers did not simply ask:

“Did testosterone go up?”

They looked at a broader physiological picture.

Measurements included:

Total testosterone

Free testosterone

DHEA

SHBG

Cortisol

HbA1c

IGF-1

Thyroid markers

Complete blood count

Lipid profile

Liver & renal parameters

Fatigue & ageing-related measures

Muscle strength

This is important because it demonstrates a more comprehensive approach to testosterone research.

The body is not just one hormone.

A meaningful testosterone-management story should consider the relationship between hormones, physical function, metabolic health & safety.

What Did the Study Find?

The clinical study reported significant increases in total testosterone in the PHYSTA® groups, with the 200 mg group showing significant differences compared with placebo at several time points.

Free testosterone also increased within the treatment groups.

At 200 mg, researchers additionally reported increases in DHEA & reductions in cortisol, alongside improvements in selected fatigue/ageing-related measures & muscle strength.

The study also monitored a range of laboratory safety parameters & reported no clinically relevant adverse changes in the measured safety laboratory parameters.

These findings are encouraging.

But they should be understood in the correct context.

They do not mean that every person taking PHYSTA® will experience the same testosterone response.

They do not mean PHYSTA® treats every cause of low testosterone.

And they do not mean a supplement should replace medically indicated treatment.

Instead, they provide human clinical evidence that supports further discussion about standardized Tongkat Ali and testosterone management.

Why Is This Different From Testosterone Replacement?

This is one of the questions people naturally ask.

Medical testosterone replacement therapy can be an appropriate treatment for men with properly diagnosed hypogonadism. However, because it introduces testosterone from outside the body, it requires appropriate diagnosis, patient selection & medical monitoring.

Potential considerations include effects on hematocrit and sperm production, among other clinical factors.

Anabolic-androgenic steroid misuse is an entirely different matter & can carry significant health risks.

PHYSTA® should not be presented as an alternative to medically necessary testosterone treatment or as a way to avoid medical care.

Its distinction is simpler:

Testosterone therapy supplies testosterone.

PHYSTA® supplies a standardized botanical extract that has been clinically studied for its potential effects on the body's hormonal environment.

That is a scientifically meaningful difference.

The PHYSTA® Testosterone Management Philosophy

The most responsible approach is not:

“How high can we make testosterone?”

It is:

“What does the individual's health profile tell us?”

That leads to a simple four-step philosophy:

1. MEASURE

Establish an appropriate baseline through clinical assessment and relevant laboratory testing.

2. SUPPORT

For suitable adults, consider evidence-supported nutritional & lifestyle strategies, including clinically researched botanical ingredients such as PHYSTA®.

3. MONITOR

Follow appropriate biomarkers & functional outcomes rather than relying entirely on subjective feelings.

4. UNDERSTAND

Interpret testosterone together with the broader picture of health, wellbeing, physical function & safety.

MEASURE → SUPPORT → MONITOR → UNDERSTAND

This is the foundation of responsible testosterone management.

The Blood Test Tells Part of the Story

A laboratory report can turn a general conversation into an objective one.

Depending on the individual & clinical context, relevant measurements may include:

Hormonal:

Total Testosterone • Free Testosterone • SHBG • DHEA

Metabolic:

HbA1c • Glucose-related markers • Lipid Profile

General Health & Safety:

CBC • Liver Function • Renal Function

Additional markers where appropriate:

Cortisol • IGF-1 • Thyroid Function

The purpose is not to suggest that PHYSTA® will improve every one of these parameters.

Rather, these measurements help healthcare professionals understand the whole physiological picture & monitor changes appropriately.

From Malaysian Heritage to Global Science

There is something particularly meaningful about this journey.

A plant deeply associated with Malaysia's traditional heritage is now being investigated using the tools of modern clinical science.

Traditional knowledge provided the beginning.

Standardization provided consistency.

Clinical research provided evidence.

Biomarkers provided measurable outcomes.

And responsible interpretation provides credibility.

That is how a traditional botanical can enter a modern international conversation not through exaggerated promises, but through research, measurement & transparency.

The PHYSTA® Story Is Not “More Testosterone.”

It is a story about better-informed testosterone management.

A story about asking the right questions.

A story about understanding the individual before making health decisions.

A story about combining traditional Malaysian botanical knowledge with modern scientific methodology.

And above all, a story about respecting the difference between a nutritional supplement, a medical treatment & an anabolic steroid.

PHYSTA® Tongkat Ali

A Science-Based Approach to Testosterone Management

From Malaysian Tradition to Modern Clinical Science.

Clinically Researched.

Objectively Measured.

Responsibly Communicated.

PHYSTA®  Science First. 


Testosterone Management
Nu-Prep.